VANCOUVER, BC / ACCESSWIRE / March 3, 2022 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused on ...
Psychedelic drug company NeonMind Biosciences Inc. NEONNMDBF(FRA:6UF) announced Thursday a strategic partnership with BioScript Solutions, a Canadian leader in specialty care. Under the terms of the ...
Lisa Matar will lead BioScript Solutions into the next stage of growth. "We're thrilled to [welcome] Lisa Matar as the first Chief Executive Officer at BioScript Solutions," said David Ford, ...
BioScript Solutions provides access to specialty drug therapies for patients with chronic illnesses and rare diseases. Since 2001, it has grown from one infusion clinic in New Brunswick to a national ...
NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
Partnered with SRx Health Solutions and BioScript Solutions to Build Out a Network of NeonMind-branded Specialty Mental Health Clinics Across Canada OAKVILLE, ON / ACCESSWIRE / April 12, 2022 / ...
Third-party logistics service offers Canadian gateway for global pharma and biotech companies TORONTO, Sept. 1, 2020 /CNW/ - BioScript Solutions, a company dedicated to providing full-service ...
MONCTON, NB , May 5, 2021 /CNW/ - BioScript Solutions ® is pleased to announce today that it has been recognized as one of Canada's Best Managed Companies. As one of the 2021 Best Managed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results